Directory
>
Justin Klee
Justin Klee
Undergraduate Neuroscience Researcher | Amylyx Pharmaceuticals
Massachusetts, Cambridge, United States
Justin Klee
Summary
Justin Klee is a dynamic leader in the biotechnology sector, currently serving as Co-Founder and Co-CEO of Amylyx Pharmaceuticals, a company dedicated to innovative solutions for neurodegenerative diseases. With a strong background in neuroscience and clinical research, Justin has been instrumental in advancing drug discovery and clinical development efforts at Amylyx since its inception in 2013. Prior to this role, he gained valuable experience as a Neurology Research Technician at Massachusetts General Hospital, where he contributed to Alzheimer's disease research. His academic foundation includes a Bachelor of Science in Neuroscience from Brown University, where he engaged in cutting-edge research on cortical communication. Justin's passion for innovation and creative problem-solving drives his commitment to improving patient outcomes in neurology. He is also known for his collaborative approach, fostering a motivated team culture at Amylyx.
Justin Klee
Work Experience
Co-Founder & Co-CEO at
Amylyx Pharmaceuticals
March 2013 - Present
Justin Klee
Education
Brown University, Bachelor of Science (B.Sc.), Neuroscience
January 2009 - January 2013
The Williams School
January 2005 - January 2009
Frequently Asked Questions about Justin Klee
What is Justin Klee email address?
Justin Klee's primary email address is ***********@amylyx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Justin Klee work for?
Justin Klee is a Undergraduate Neuroscience Researcher at Amylyx Pharmaceuticals.
Where Justin Klee graduated from?
Justin Klee holds a degree in null from Brown University.
How can I directly contact Justin Klee?
To contact Justin Klee directly, you can use the email address ***********@amylyx.com. Complete contact information is available upon registration with Muraena.
Who is Justin Klee?
Justin Klee is a dynamic leader in the biotechnology sector, currently serving as Co-Founder and Co-CEO of Amylyx Pharmaceuticals, a company dedicated to innovative solutions for neurodegenerative diseases. With a strong background in neuroscience and clinical research, Justin has been instrumental in advancing drug discovery and clinical development efforts at Amylyx since its inception in 2013. Prior to this role, he gained valuable experience as a Neurology Research Technician at Massachusetts General Hospital, where he contributed to Alzheimer's disease research. His academic foundation includes a Bachelor of Science in Neuroscience from Brown University, where he engaged in cutting-edge research on cortical communication. Justin's passion for innovation and creative problem-solving drives his commitment to improving patient outcomes in neurology. He is also known for his collaborative approach, fostering a motivated team culture at Amylyx.